These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19204064)

  • 21. Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.
    Michaelides M; Pascau J; Gispert JD; Delis F; Grandy DK; Wang GJ; Desco M; Rubinstein M; Volkow ND; Thanos PK
    Eur J Neurosci; 2010 Aug; 32(4):668-76. PubMed ID: 20646063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of test experience and NK1 receptor antagonists on the performance of NK1R-/- and wild type mice in the 5-Choice Serial Reaction-Time Task.
    Weir RK; Dudley JA; Yan TC; Grabowska EM; Peña-Oliver Y; Ripley TL; Stephens DN; Stanford SC; Hunt SP
    J Psychopharmacol; 2014 Mar; 28(3):270-81. PubMed ID: 23845920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
    J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice.
    Won H; Mah W; Kim E; Kim JW; Hahm EK; Kim MH; Cho S; Kim J; Jang H; Cho SC; Kim BN; Shin MS; Seo J; Jeong J; Choi SY; Kim D; Kang C; Kim E
    Nat Med; 2011 May; 17(5):566-72. PubMed ID: 21499268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice.
    Huotari M; García-Horsman JA; Karayiorgou M; Gogos JA; Männistö PT
    Psychopharmacology (Berl); 2004 Feb; 172(1):1-10. PubMed ID: 14574438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychostimulants, antidepressants and neurokinin-1 receptor antagonists ('motor disinhibitors') have overlapping, but distinct, effects on monoamine transmission: the involvement of L-type Ca2+ channels and implications for the treatment of ADHD.
    Stanford SC
    Neuropharmacology; 2014 Dec; 87():9-18. PubMed ID: 24727210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attention-Deficit/Hyperactivity Disorder-like Phenotype in a Mouse Model with Impaired Actin Dynamics.
    Zimmermann AM; Jene T; Wolf M; Görlich A; Gurniak CB; Sassoè-Pognetto M; Witke W; Friauf E; Rust MB
    Biol Psychiatry; 2015 Jul; 78(2):95-106. PubMed ID: 24768258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cAMP and extracellular signal-regulated kinase signaling in response to d-amphetamine and methylphenidate in the prefrontal cortex in vivo: role of beta 1-adrenoceptors.
    Pascoli V; Valjent E; Corbillé AG; Corvol JC; Tassin JP; Girault JA; Hervé D
    Mol Pharmacol; 2005 Aug; 68(2):421-9. PubMed ID: 15890841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
    Rupniak NM; Carlson EJ; Webb JK; Harrison T; Porsolt RD; Roux S; de Felipe C; Hunt SP; Oates B; Wheeldon A
    Behav Pharmacol; 2001 Nov; 12(6-7):497-508. PubMed ID: 11742144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.
    Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
    Behav Brain Res; 1998 Jul; 94(1):163-71. PubMed ID: 9708847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.
    Mehler-Wex C; Riederer P; Gerlach M
    Neurotox Res; 2006 Dec; 10(3-4):167-79. PubMed ID: 17197367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.
    dos Santos Pereira M; Sathler MF; Valli Tda R; Marques RS; Ventura AL; Peccinalli NR; Fraga MC; Manhães AC; Kubrusly R
    PLoS One; 2015; 10(10):e0141249. PubMed ID: 26509840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.
    Thanos PK; Bermeo C; Rubinstein M; Suchland KL; Wang GJ; Grandy DK; Volkow ND
    J Psychopharmacol; 2010 Jun; 24(6):897-904. PubMed ID: 19282420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD.
    Cherkasova MV; Faridi N; Casey KF; O'Driscoll GA; Hechtman L; Joober R; Baker GB; Palmer J; Dagher A; Leyton M; Benkelfat C
    Neuropsychopharmacology; 2014 May; 39(6):1498-507. PubMed ID: 24378745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
    del Campo N; Fryer TD; Hong YT; Smith R; Brichard L; Acosta-Cabronero J; Chamberlain SR; Tait R; Izquierdo D; Regenthal R; Dowson J; Suckling J; Baron JC; Aigbirhio FI; Robbins TW; Sahakian BJ; Müller U
    Brain; 2013 Nov; 136(Pt 11):3252-70. PubMed ID: 24163364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
    Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
    Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.